Much evidence points to tau- and amyloid-related cellular alterations as major contributing factors to the pathogenesis of Alzheimer's disease (AD). Although numerous studies of neuronal pathology have been carried out in the human brain, they have rarely been performed in a way to assess the effects of the progression of pathological lesions on the morphologic integrity of identified neuronal subpopulations and have generally not been quantitative. This project will investigate the spatial and temporal linkage between abnormally phosphorylated tau and amyloid accumulation, and dendritic atrophy and spine loss in different subtypes of neocortical pyramidal cells characterized by neurochemical and morphologic features. Such putative interactions will be investigated in four groups of human postmortem specimens: 1) neurologically normal elderly cases, 2) cases with mild cognitive impairment and early AD, 3) cases with moderate dementia, and 4) severe AD cases, as well as in a mouse model that expresses only the human tau gene. The early AD cases will emerge as a particularly interesting group of brains as they will permit us to pinpoint the earliest changes in dendritic function in neocortical neurons that have a known risk of enhanced vulnerability to the degenerative process of AD. Based on stereologic analyses from our laboratory, we expect that a small subgroup of large neocortical neurons enriched in nonphosphorylated neurofilaments are the first to contain dendritic lesions that precede the stage at which neurofibrillary tangles (NFT) are forming and dementia becomes evident. These analyses will focus on Brodmann's area 9 in the prefrontal cortex. Area 9 is a severely and early affected neocortical field in AD, which we have extensively characterized in terms of selective neuronal vulnerability. In this project we will expand the regional stereologic assessments of identified neuronal subgroups gathered during the previous funding period by analyzing cellular alterations and their relationships to deposition of amyloid and age-related neuronal pathology at the level of individual neuron morphology. The analyses in mice will permit us to follow the dynamic changes in live animals, obtain very high resolution imaging datasets prior to sectioning these specimens for detailed morphologic analyses, and provide quantitative analyses of neurons potentially at risk of degeneration with a much higher level of resolution than would be achievable in human postmortem materials. Altogether this project will provide a quantitative assessment, in AD cases of different severity, of the relative contribution of age-related neuritic pathology, early stages of amyloid processing, and senile plaques, to the progressive demise of selectively vulnerable neuronal subsets subserving cortical circuits critical for memory and cognition.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005138-21A1
Application #
6932683
Study Section
Special Emphasis Panel (ZAG1-ZIJ-7 (J4))
Project Start
2005-04-01
Project End
2010-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
21
Fiscal Year
2005
Total Cost
$125,000
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Hauberg, Mads E; Fullard, John F; Zhu, Lingxue et al. (2018) Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls. Mol Psychiatry :
Giambartolomei, Claudia; Zhenli Liu, Jimmy; Zhang, Wen et al. (2018) A Bayesian framework for multiple trait colocalization from summary association statistics. Bioinformatics 34:2538-2545
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124
Agrawal, A; Chou, Y-L; Carey, C E et al. (2018) Genome-wide association study identifies a novel locus for cannabis dependence. Mol Psychiatry 23:1293-1302
Brenowitz, Willa D; Han, Fang; Kukull, Walter A et al. (2018) Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults. Neurobiol Aging 62:64-71
Dobbyn, Amanda; Huckins, Laura M; Boocock, James et al. (2018) Landscape of Conditional eQTL in Dorsolateral Prefrontal Cortex and Co-localization with Schizophrenia GWAS. Am J Hum Genet 102:1169-1184
Cruchaga, Carlos; Del-Aguila, Jorge L; Saef, Benjamin et al. (2018) Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms. Alzheimers Dement 14:205-214
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Kinnunen, Kirsi M; Cash, David M; Poole, Teresa et al. (2018) Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study. Alzheimers Dement 14:43-53

Showing the most recent 10 out of 555 publications